EpiAxis Therapeutics to present at Biotech Showcase 2023

EpiAxis Therapeutics to present at Biotech Showcase 2023

EpiAxis Therapeutics, a leading LSD1 company with a focus on the treatment, diagnosis and monitoring of cancer and the prevention of its recurrence, is presenting at Biotech Showcase™ 2023. EpiAxis CEO Dr Jeremy Chrisp will discuss the company's focus on developing...

read more

 

Professor Sudha Rao